Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $416,000 | -43.2% | 25,674 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $733,000 | -15.6% | 25,674 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $868,000 | +11.9% | 25,674 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $776,000 | -23.8% | 25,674 | +24.7% | 0.01% | -20.0% |
| Q4 2020 | $1,019,000 | +29.0% | 20,584 | 0.0% | 0.01% | +11.1% |
| Q3 2020 | $790,000 | -11.1% | 20,584 | 0.0% | 0.01% | -18.2% |
| Q2 2020 | $889,000 | +48.2% | 20,584 | -10.5% | 0.01% | +37.5% |
| Q1 2020 | $600,000 | +30.7% | 22,992 | +56.4% | 0.01% | +60.0% |
| Q4 2019 | $459,000 | – | 14,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |